Clinical trial
Role of Pioglitazone in Preventing Diabetes
NCT00276497 · M.V. Hospital for Diabetes, Other · Completed
Key facts
| NCT number | NCT00276497 |
|---|---|
| Title | Role of Pioglitazone in Preventing Diabetes |
| Lead sponsor | M.V. Hospital for Diabetes, Other |
| Collaborators | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| Start date | Oct 1, 2003 |
| Completion | May 1, 2008 |
| First posted | Jan 13, 2006 |
| Last update posted | Apr 6, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: